139 related articles for article (PubMed ID: 1263740)
1. Relationship between the subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in rat brain and the duration of the effect on motor activity.
Magour S; Coper H; Fähndrich C; Hill R
Life Sci; 1976 Mar; 18(6):575-84. PubMed ID: 1263740
[No Abstract] [Full Text] [Related]
2. Subcellular distribution of delta9-tetrahydrocannabinol in rat brain.
Colburn RW; Ng LK; Lemberger L; Kopin IJ
Biochem Pharmacol; 1974 Feb; 23(4):873-7. PubMed ID: 4824510
[No Abstract] [Full Text] [Related]
3. Effect of delta-9-tetrahydrocannabinol administration on the lipid constituents of rat brain subcellular fractions.
Sarkar C; Ghosh JJ
J Neurochem; 1975 Feb; 24(2):381-5. PubMed ID: 1113115
[No Abstract] [Full Text] [Related]
4. The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.
Gill EW; Lawrence DK
J Pharm Pharmacol; 1973 Dec; 25(12):948-52. PubMed ID: 4150297
[No Abstract] [Full Text] [Related]
5. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.
Gill EW; Jones G; Lawrence DK
Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251
[No Abstract] [Full Text] [Related]
6. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
Ben-Zvi Z; Mechoulam R; Edery H; Porath G
Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
[TBL] [Abstract][Full Text] [Related]
7. Effect of delta-9-tetrahydrocannabinol on gangliosides and sialoglycoproteins in subcellular fractions of rat brain.
Sarkar C; Ghosh JJ
J Neurochem; 1976 Apr; 26(4):721-3. PubMed ID: 965964
[No Abstract] [Full Text] [Related]
8. Is tolerance to delta-9-THC cellular or metabolic? The subcellular distribution of delta-9-tetrahydrocannabinol and its metabolites in brains of tolerant and non-tolerant rats.
Magour S; Coper H; Fähndrich C
Psychopharmacology (Berl); 1977 Jan; 51(2):141-5. PubMed ID: 402665
[TBL] [Abstract][Full Text] [Related]
9. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
Lawrence DK; Pertwee RG
Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
[TBL] [Abstract][Full Text] [Related]
10. Blood and brain levels of delta1-tetrahydrocannabinol in mice--the effect of 7-hydroxy-delta1-tetrahydrocannabinol.
Gill EW; Lawrence DK
Biochem Pharmacol; 1974 Mar; 23(6):1140-3. PubMed ID: 4824912
[No Abstract] [Full Text] [Related]
11. 9-Nor-delta8-tetrahydrocannabinol, a cannabinoid of metabolic interest.
Wilson RS; May EL
J Med Chem; 1974 Apr; 17(4):475-6. PubMed ID: 4830548
[No Abstract] [Full Text] [Related]
12. Distribution studies of (14C)delta-9-tetrahydrocannabinol in mice: effect of vehicle, route of administration, and duration of treatment.
Mantilla-Plata B; Harbison RD
Toxicol Appl Pharmacol; 1975 Nov; 34(2):292-300. PubMed ID: 1209626
[No Abstract] [Full Text] [Related]
13. The membrane binding of morphine, diphenylhydantoin, and tetrahydrocannabinol.
Seeman P; Chau-Wong M; Moyyen S
Can J Physiol Pharmacol; 1972 Dec; 50(12):1193-200. PubMed ID: 4655051
[No Abstract] [Full Text] [Related]
14. Delta-9-tetrahydrocannabinol: localization in body fat.
Kreuz DS; Axelrod J
Science; 1973 Jan; 179(4071):391-3. PubMed ID: 4682965
[TBL] [Abstract][Full Text] [Related]
15. Cannabinol: a rapidly formed metabolite of delta-1- and delta-6-tetrahydrocannabinol.
McCallum ND; Yagen B; Levy S; Mechoulam R
Experientia; 1975 May; 31(5):520-1. PubMed ID: 1140243
[No Abstract] [Full Text] [Related]
16. The facilitating and suppressing effects of delta 9-tetrahydrocannabinol on the rise in intrasynaptosomal Ca2+ concentration in rats.
Okada M; Urae A; Mine K; Shoyama Y; Iwasaki K; Fujiwara M
Neurosci Lett; 1992 Jun; 140(1):55-8. PubMed ID: 1328966
[TBL] [Abstract][Full Text] [Related]
17. Modification of delta9-THC-actions by cannabinol and cannabidiol in the rat.
Fernandes M; Schabarek A; Coper H; Hill R
Psychopharmacologia; 1974; 38(4):329-38. PubMed ID: 4473791
[No Abstract] [Full Text] [Related]
18. Characteristics of D-lysergic acid diethylamide binding to subcellular fractions derived from rat brain.
Farrow JT; Van Vunakis H
Biochem Pharmacol; 1973 May; 22(9):1103-13. PubMed ID: 4695669
[No Abstract] [Full Text] [Related]
19. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol.
Levy S; McCallum NK
Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
